Bright Minds Biosciences (DRUG) Cash from Investing Activities (2020)

Bright Minds Biosciences (DRUG) reported Cash from Investing Activities of -$17546.4 for Q4 2020.

Bright Minds Biosciences (DRUG) Cash from Investing Activities (2020) Analysis & Trends

Bright Minds Biosciences has reported Cash from Investing Activities for 1 years, with the latest figure at -$17546.4 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Investing Activities (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-2.89 Mn
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	638.50 Mn
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	-431.90 Mn
9	Abivax	90.15 Bn	90.15 Bn	-	579,519.10
10	Bright Minds Biosciences	16.28 Bn	16.22 Bn	-	-

Download Data

Date	Value
Dec 31, 2020	-17,546.38
Dec 31, 2020	-17,546.38